Scarica l'app Stockscreener
1.62
6.36%
-0.11
Dopo l'orario di chiusura:
1.66
0.04
+2.47%
Precedente Chiudi:
$1.73
Aprire:
$1.75
Volume 24 ore:
923.22K
Relative Volume:
1.02
Capitalizzazione di mercato:
$102.39M
Reddito:
$139.77M
Utile/perdita netta:
$-97.62M
Rapporto P/E:
-1.0253
EPS:
-1.58
Flusso di cassa netto:
$-61.71M
1 W Prestazione:
+1.89%
1M Prestazione:
+8.72%
6M Prestazione:
-25.69%
1 anno Prestazione:
-52.21%
Intervallo 1D:
$1.60
$1.75
Intervallo di 1 settimana:
$1.46
$1.75
Portata 52W:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
Nome
Macrogenics Inc
Settore
Industria
Telefono
301-251-5172
Indirizzo
9704 MEDICAL CENTER DRIVE, Rockville, MD
Confronta MGNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.62 | 109.35M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Ripresa | Barclays | Overweight |
| 2024-11-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-07-31 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-05-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | Downgrade | Stifel | Buy → Hold |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2024-04-26 | Iniziato | B. Riley Securities | Buy |
| 2024-04-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-03-04 | Reiterato | BTIG Research | Buy |
| 2024-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-11-22 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-11-14 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-02-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-04 | Iniziato | SMBC Nikko | Outperform |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Aggiornamento | Barclays | Underweight → Overweight |
| 2020-12-22 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-03 | Downgrade | Citigroup | Buy → Neutral |
| 2020-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2019-12-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-11-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-05-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2019-04-12 | Iniziato | Guggenheim | Neutral |
| 2019-02-07 | Aggiornamento | Citigroup | Sell → Buy |
| 2019-02-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-02-06 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | Downgrade | Citigroup | Neutral → Sell |
| 2018-12-10 | Downgrade | Raymond James | Outperform → Underperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-03-05 | Iniziato | H.C. Wainwright | Buy |
| 2017-03-31 | Iniziato | Raymond James | Outperform |
Mostra tutto
Macrogenics Inc Borsa (MGNX) Ultime notizie
Acadian Asset Management LLC Buys 1,017,726 Shares of MacroGenics, Inc. $MGNX - MarketBeat
What indicators show strength in MacroGenics Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
Live market analysis of MacroGenics Inc.Earnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Using economic indicators to assess MacroGenics Inc. potential2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
MacroGenics (NASDAQ:MGNX) Rating Increased to Strong-Buy at Barclays - MarketBeat
MacroGenics Inc. stock trend outlook and recovery pathDay Trade & Daily Technical Stock Forecast Reports - newser.com
Growth Recap: Will MacroGenics Inc outperform the market in YEARJuly 2025 Sentiment & Fast Entry High Yield Tips - khodrobank.com
Macro Review: Why is Alpha Modus Holdings Inc Equity Warrant stock going upEarnings Trend Report & Smart Money Movement Tracker - khodrobank.com
MacroGenics Inc. recovery potential after sell off2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Quarterly Earnings: What is MacroGenics Inc.’s market positionJuly 2025 Movers & Weekly High Conviction Trade Ideas - khodrobank.com
Insider Buy: What makes MacroGenics Inc stock attractive todayTrade Entry Summary & Reliable Price Breakout Signals - khodrobank.com
Intraday pattern recognizer results for MacroGenics Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Barclays Begins Coverage on MacroGenics (NASDAQ:MGNX) - MarketBeat
MGNX Stock: Barclays Assumes Overweight Rating with $3 Price Tar - GuruFocus
How sentiment analysis helps forecast MacroGenics Inc.IPO Watch & Entry Point Strategy Guides - newser.com
MacroGenics, Inc. (NASDAQ:MGNX) Receives $3.60 Consensus Price Target from Brokerages - MarketBeat
Visualizing MacroGenics Inc. stock with heatmapsEarnings Risk Report & Fast Gain Swing Alerts - newser.com
Volatility clustering patterns for MacroGenics Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
MacroGenics assumed with an Overweight at Barclays - TipRanks
Buy Signal: What is the next catalyst for MacroGenics IncBuy Signal & Weekly High Potential Stock Alerts - خودرو بانک
Macro Review: Is HCSG stock a falling knife or bargain buyPortfolio Update Report & Expert Verified Stock Movement Alerts - khodrobank.com
Fed Watch: Is reAlpha Tech Corp. a turnaround storyJuly 2025 Setups & Advanced Technical Analysis Signals - خودرو بانک
Statistical indicators supporting MacroGenics Inc.’s strengthTrade Performance Summary & Weekly High Potential Alerts - newser.com
Downgrade Watch: What is MacroGenics Inc. s 5 year growth outlook2025 Growth vs Value & Trade Opportunity Analysis - خودرو بانک
Hedge Fund Bets: Can MacroGenics Inc. grow without dilutionMarket Risk Analysis & Reliable Price Breakout Alerts - خودرو بانک
Investment Report: Can LFUS lead its sector in growthMarket Growth Report & High Accuracy Investment Signals - خودرو بانک
Stock Analysis: Can MacroGenics Inc. reach all time highs this yearChart Signals & Precise Swing Trade Entry Alerts - خودرو بانک
Sentiment Review: What makes MacroGenics Inc stock attractive todayTrade Entry Report & Long-Term Safe Investment Ideas - khodrobank.com
Fund Flows: Can MacroGenics Inc be the next market leaderJuly 2025 Drop Watch & Accurate Buy Signal Notifications - khodrobank.com
Take Profit: Is MacroGenics Inc. stock forming a triangle patternJuly 2025 PostEarnings & Entry Point Strategy Guides - khodrobank.com
Analyst Calls: What is MacroGenics Inc. s 5 year growth outlook2025 Sector Review & Verified Momentum Stock Alerts - khodrobank.com
Multi asset correlation models including MacroGenics Inc.Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Nuveen LLC Purchases Shares of 198,470 MacroGenics, Inc. $MGNX - MarketBeat
Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Cuts Target Price to $4 - 富途牛牛
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances By Investing.com - Investing.com South Africa
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances - Investing.com India
Published on: 2025-09-08 14:52:02 - beatles.ru
MacroGenics Inc. Flashes Buy Signal on Multi Timeframe ChartJuly 2025 Earnings & Fast Entry Momentum Alerts - beatles.ru
Long term hold vs stop loss in MacroGenics Inc.Buy Signal & Accurate Buy Signal Notifications - Newser
Can MacroGenics Inc. reach all time highs this yearPortfolio Growth Summary & Technical Analysis for Trade Confirmation - خودرو بانک
What is MacroGenics Inc.’s market position2025 Growth vs Value & Short-Term Trading Alerts - خودرو بانک
What is the next catalyst for MacroGenics Inc.Portfolio Performance Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Top chart patterns to watch in MacroGenics Inc.Weekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Can MacroGenics Inc. stock double in the next yearEarnings Beat & Real-Time Volume Analysis - خودرو بانک
Will MacroGenics Inc. benefit from macro trendsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
MacroGenics' Strategic Divestitures and Implications for Biotech Innovation - AInvest
MacroGenics: Struggling Wheeler- Dealer Dealt Away Its Best Bets (NASDAQ:MGNX) - Seeking Alpha
Can MacroGenics Inc. recover in the next quarterLayoff News & Smart Swing Trading Techniques - Newser
What to do if you’re stuck in MacroGenics Inc.Market Activity Recap & AI Optimized Trade Strategies - Newser
Smart tools for monitoring MacroGenics Inc.’s price actionJuly 2025 Patterns & Safe Entry Momentum Tips - Newser
Macrogenics, Inc. shares rise 2.58% premarket after Johnson & Johnson's Alzheimer research progress and AstraZeneca's successful drug trial. - AInvest
Macrogenics Inc Azioni (MGNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):